Cardiovascular risks post-COVID-19 vaccination: Key findings

FHS
October 3, 2024
10:29 am

Researchers explore the risks of cardiovascular and cerebrovascular events following vaccination against the COVID-19.

AffyImmune’s layoffs; Henlius makes a biosimilar deal with Dr. Reddy’s

Plus, news about X4 Pharmaceuticals, Viracta Therapeutics, Crown Laboratories, Qlaris and Hitachi. AffyImmune’s layoffs: The CAR-T biotech went through a round of layoffs and restructuring

February 7, 2025

Risk Adjusted Net Present Value: What is the current valuation of Revolution Medicines’s RMC-6236

The revenue for RMC-6236 is expected to reach an annual total of $268 mn by 2035 in the US based off GlobalDatas Expiry Model. The

September 8, 2024

Humana tumbles as insurer faces $3 billion hit to revenue over lower Medicare star ratings

Business of Health Care Reporter Bob Herman covers health insurance, government programs, hospitals, physicians, and other providers — reporting on how money influences those businesses

October 2, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.